Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 6988-6994
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6988
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6988
Clinical characteristics | ASCA IgG | ASCA IgA | ∆IgG | ∆IgA |
Correlation with age | c = –0.140 | c = 0.198 | c = –0.340 | c = –0.197 |
Male vs female | 0.881 | 0.881 | 0.089 | 0.571 |
Disease Location | ||||
Colonic vs non-colonic | 0.667 | 0.169 | 0.203 | 0.289 |
Ileal vs non-ileal | 0.285 | 0.285 | 0.032a | 0.395 |
Fistular vs Non-fistular disease | 0.152 | 0.075 | 0.499 | 0.907 |
Medical therapy | ||||
Azathioprine | 0.881 | 0.881 | 0.749 | 0.375 |
Infliximab | 0.233 | 0.233 | 0.87 | 0.844 |
5-ASA compounds | 0.806 | 0.233 | 0.903 | 0.491 |
Oral steroids | 0.512 | 0.385 | 0.475 | 0.531 |
None of the above medical | ||||
therapy vs medical therapy | 0.285 | 0.577 | 0.438 | 0.117 |
-
Citation: Müller S, Styner M, Seibold-Schmid B, Flogerzi B, Mähler M, Konrad A, Seibold F. Anti-
Saccharomyces cerevisiae antibody titers are stable over time in Crohn’s patients and are not inducible in murine models of colitis. World J Gastroenterol 2005; 11(44): 6988-6994 - URL: https://www.wjgnet.com/1007-9327/full/v11/i44/6988.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i44.6988